AIMP1
AIMP1, also known as EMAPII, EMAP-2, p43 and SCYE1, is a non-catalytic component of the multi-tRNA synthetase complex that also acts as an inflammatory cytokine. It links protein synthesis machinery to angiogenesis, inflammation and wound healing. Browse Assay Genie's current range of AIMP1 research reagents below, or read on for the biology behind the target.
AIMP1 has two distinct roles. Inside the cell it is a non-catalytic component of the multisynthase complex, where it binds tRNA and stimulates the catalytic activity of cytoplasmic arginyl-tRNA synthase. The precursor protein is identical to the p43 subunit of the multi-tRNA synthetase complex and modulates aminoacylation activity in normal cells. Outside the cell, after release and proteolytic cleavage in tumour cells, it acts as a cytokine and stimulates inflammatory responses.
As a secreted factor, AIMP1 is specifically induced by apoptosis and is involved in the control of angiogenesis, inflammation and wound healing. It induces endothelial cell migration at low concentrations and endothelial cell apoptosis at high concentrations, and it degrades HIF-1A through interaction with PSMA7. Its release renders tumour-associated vasculature sensitive to tumour necrosis factor. It also induces dendritic cell maturation and monocyte adhesion, and promotes dermal fibroblast proliferation and wound repair.
Further activities include negative regulation of TGF-beta signalling, by binding SMURF2 and inhibiting its SMAD7-mediated degradation, and regulation of KDELR1-mediated retention of HSP90B1/gp96 in the endoplasmic reticulum. AIMP1 also contributes to glucose homeostasis by inducing glucagon secretion at low glucose levels. The protein is found in the nucleus, cytosol, endoplasmic reticulum and Golgi apparatus, and is secreted. The AIMP1 gene produces multiple transcript variants encoding different isoforms, and a pseudogene lies on chromosome 20. The former name was small inducible cytokine subfamily E, member 1 (endothelial monocyte-activating); the mouse ortholog is Aimp1.
AIMP1 induces endothelial cell migration at low concentrations and apoptosis at high concentrations, making it a useful factor for studying vascular responses.
AIMP1 has inflammatory cytokine activity and induces dendritic cell maturation and monocyte cell adhesion.
Release of AIMP1 renders tumour-associated vasculature sensitive to tumour necrosis factor, linking it to cancer-related vascular studies.
AIMP1 promotes dermal fibroblast proliferation and wound repair, and induces glucagon secretion at low glucose levels.
AIMP1 is a non-catalytic part of the multisynthase complex that binds tRNA and stimulates arginyl-tRNA synthase. It is also a secreted cytokine involved in angiogenesis, inflammation and wound healing, and it negatively regulates TGF-beta signalling by stabilising SMURF2.
AIMP1 is also called EMAPII, EMAP-2, p43 and SCYE1. The earlier name was small inducible cytokine subfamily E, member 1 (endothelial monocyte-activating). The gene produces multiple transcript variants encoding different isoforms, so the name p43 and EMAP-II can refer to different forms of the protein.
A mouse ortholog, Aimp1, is recorded for the human gene. A pseudogene has also been identified on chromosome 20 in humans. For experimental work in other species, check the datasheet of any product for its validated reactivity.
Binding partners and pathway components linked to AIMP1 function, including TGF-beta signalling, hypoxia response and endoplasmic reticulum retention.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q12904; product specifications from Assay Genie datasheets.